We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $579M
1-Year Est. Return 94.36%
This Fund
S&P 500
This Quarter Est. Return
+4.36%
1 Year Est. Return
+94.36%
3 Year Est. Return
+196.81%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$401M
AUM Growth
-$49.1M
Cap. Flow
-$51.9M
Cap. Flow %
-12.95%
Top 10 Hldgs %
77.61%
Holding
82
New
5
Increased
1
Reduced
3
Closed
2

Top Buys

1
IMMX icon
Immix Biopharma
IMMX
+$3.29M
2
CUE icon
Cue Biopharma
CUE
+$2.35M
3
MODD icon
Modular Medical
MODD
+$1.25M
4
IPWR icon
Ideal Power
IPWR
+$1.2M
5
TALK icon
Talkspace
TALK
+$680K

Top Sells

1
BC icon
Brunswick
BC
+$48.4M
2
LIN icon
Linde
LIN
+$11M
3
BLUE
bluebird bio
BLUE
+$1.87M
4
SLGCW
SomaLogic, Inc. Warrant
SLGCW
+$1.68K
5
FAZEW
FaZe Holdings Inc. Warrant
FAZEW
+$323

Sector Composition

1 Healthcare 17.02%
2 Industrials 16.95%
3 Materials 10.55%
4 Consumer Discretionary 10.23%
5 Financials 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WBD icon
76
Warner Bros
WBD
$67.6B
$3.48K ﹤0.01%
399
– –
WGS icon
77
GeneDx Holdings
WGS
$1.87B
$2.78K ﹤0.01%
304
– –
AVNW icon
78
Aviat Networks
AVNW
$270M
$2.53K ﹤0.01%
66
– –
FNCH
79
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$2.52K ﹤0.01%
971
– –
ASTR
80
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$353 ﹤0.01%
517
– –
FAZEW
81
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
– –
-75,000
Closed -$323
SLGCW
82
DELISTED
SomaLogic, Inc. Warrant
SLGCW
– –
-14,020
Closed -$1.68K
1 2 3
4

Similar funds

BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
LRIA
Leonard Rickey Investment Advisors Yakima, Washington $578M AUM 16.23% 1-Year Est. Return
WCCM
Webs Creek Capital Management Dallas, Texas $578M AUM 79.84% 1-Year Est. Return
MIOT
Massachusetts Institute of Technology Cambridge, Massachusetts $577M AUM 8.5% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
GCM
Gibraltar Capital Management Tulsa, Oklahoma $581M AUM 18.65% 1-Year Est. Return
KNW
Kesler Norman & Wride Ogden, Utah $581M AUM 17.6% 1-Year Est. Return

Bleichroeder LP's Q1 2024 Portfolio in Review

As of Q1 2024, Bleichroeder LP held 82 positions worth $401M, down 11% from $450M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Bleichroeder LP withdrew a net $51.9M in Q1 2024, closing 2 positions and reducing 3 holdings. Its most notable exit was SomaLogic, Inc. Warrant, an estimated $1.68K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Materials.

Against the trend, Bleichroeder LP opened a new position in Immix Biopharma worth $2.61M.

  • Bleichroeder LP's largest Q1 2024 buy was Immix Biopharma: 850,000 shares worth $2.61M.
  • Bleichroeder LP added most to Cue Biopharma in Q1 2024, an estimated $2.35M increase.
  • Bleichroeder LP's biggest Q1 2024 reduction was Brunswick, cutting an estimated $48.4M.
  • Bleichroeder LP fully exited SomaLogic, Inc. Warrant in Q1 2024, selling an estimated $1.68K.
  • Bleichroeder LP's ten largest holdings make up 78% of its $401M portfolio in Q1 2024.
  • Bleichroeder LP opened 5 new positions and closed 2 in Q1 2024.
  • Bleichroeder LP's portfolio value fell 11% quarter-over-quarter to $401M.

Based on Bleichroeder LP's 13F filing for Q1 2024, filed 14 May 2024.